Is ovarian cancer ascitic fluid pH alkaline?
Best insight from top research papers
Ovarian cancer ascitic fluid has an alkaline pH. The pH of ascites in stage II-III ovarian cancer patients is 7.51 ± 0.16, while in stage IV patients it is 7.78 ± 0.16 . The overall extracellular (peritoneal) environment is also alkaline .
Answers from top 5 papers
More filters
| Papers (5) | Insight |
|---|---|
Open access•Journal Article | The provided paper does not mention the pH of ovarian cancer ascitic fluid. |
Open access•Journal Article 24 Citations | The provided paper does not mention the pH of ovarian cancer ascitic fluid. |
15 Citations | The paper does not provide information about the pH of ovarian cancer ascitic fluid. |
29 Sep 2022 | The paper states that the overall extracellular (peritoneal) environment of the ascites in ovarian cancer patients was alkaline, with pH values of 7.51 ± 0.16 for stage II-III and 7.78 ± 0.16 for stage IV. Therefore, the ovarian cancer ascitic fluid pH is alkaline. |
| The provided paper does not mention the pH of ovarian cancer ascitic fluid. The paper is about optimizing two-dimensional gel electrophoresis to identify intracellular cisplatin-protein adducts in ovarian cancer cells. |
Related Questions
What is the prevalence of HBOC in ovarian cancer?5 answersThe prevalence of hereditary breast and ovarian cancer (HBOC) in ovarian cancer varies based on genetic testing results. Studies have shown that among patients with ovarian cancer, a significant percentage carry deleterious mutations in HBOC susceptibility genes. Specifically, in a study involving 429 ovarian cancer patients, 48.6% were found to have deleterious mutations in these genes, with a notable enrichment in individuals with a family history of breast or ovarian cancer syndrome. This highlights the importance of genetic testing for HBOC in ovarian cancer patients to enable increased clinical surveillance, early detection, and potentially predict responses to treatments like PARP inhibitors. Such testing can aid in identifying individuals at higher risk and guide personalized management strategies for improved outcomes.
Pathophysiology of ovarian cancer?4 answersOvarian cancer is a complex disease with various histotypes, including serous, endometrioid, clear cell, mucinous, and transitional cell carcinomas. The pathophysiology involves factors like gene signatures, molecular tumor diversity, and acquired chemoresistance, leading to challenges in treatment and high recurrence rates. Recent studies suggest that high-grade serous ovarian carcinoma (HGSOC) may originate from the fallopian tubes, with early events like p53 signatures and serous tubal intraepithelial carcinoma, before seeding to the ovaries. Computational pathology is emerging as a valuable tool to extract latent data from tissue sections, aiding in diagnosing and managing ovarian cancer by quantifying spatial and morphologic patterns for better understanding of tumor biology and potential early detection strategies.
How does ovarian cancer afeccts lide?5 answersOvarian cancer significantly impacts life due to its high mortality rates and challenges in early diagnosis. It is the most lethal gynecological malignancy and the fifth leading cause of cancer death in women, with varying incidence rates globally. Factors contributing to ovarian cancer risk include genetic mutations like BRCA1 and BRCA2, hormonal influences, environmental exposures, and lifestyle choices. The disease's complexity is further highlighted by the presence of ovarian cancer stem cells, which play a crucial role in recurrence and progression. Immunotherapy is being actively investigated as a potential treatment approach, aiming to stimulate tumor-specific effector T cells and prevent disease progression. Overall, the impact of ovarian cancer on life underscores the importance of continuous research, early detection strategies, and advancements in treatment modalities to improve outcomes and quality of life for affected individuals.
Most cancer has lower PH?4 answersCancer cells commonly exhibit lower pH levels compared to normal healthy tissues due to factors like increased glycolytic rates, hypoxia, and inadequate blood supply, leading to tumor acidosis. This acidic tumor microenvironment plays a crucial role in cancer progression by promoting invasion, metastasis, resistance to therapies, angiogenesis, and immune evasion. pH-sensitive agents like pHLIPs have been developed to target cancer cells based on their low pH, showing promise in delivering imaging and therapeutic agents to tumors. Strategies to manipulate tumor pH, such as raising extracellular pH with sodium bicarbonate or inhibiting proton pumps, have shown potential therapeutic benefits in preclinical studies, highlighting the importance of pH modulation in cancer therapy.
What kind of biomaterial is profit to the ovary cancer?5 answersBiomaterials play a crucial role in ovarian cancer research, with various types showing promise in different aspects. Collagen type I and marine collagen from jellyfish have been tested as biomaterial candidates for cancer studies, offering tuneable mechanical properties and compatibility with cellular and molecular assays. Self-assembling peptides have also been highlighted as a promising biomaterial platform to study ovarian cancer, mimicking the tumor microenvironment and enabling realistic cell behaviors. Furthermore, injectable hydrogels like collagen type I have been found to best support tumor formation by ovarian cancer cells in vivo, closely resembling human ovarian carcinoma characteristics. These biomaterials provide valuable tools for modeling the tumor microenvironment, studying cancer progression, and testing novel therapeutic strategies in ovarian cancer research.
Role of ALOX5AP in ovarian cancer?5 answersALOX5AP, Arachidonate 5-Lipoxygenase Activating Protein, plays a crucial role in ovarian cancer progression. Studies have shown that elevated ALOX5AP expression is significantly associated with poor overall survival, progression-free survival, and adverse clinicopathological features in serous ovarian cancer patients. Mechanistically, ALOX5AP is primarily involved in immune response and regulation, particularly in the immunoreactive subtype of ovarian cancer, where it correlates with immunocyte infiltration, especially M2 macrophage polarization. This suggests that ALOX5AP may serve as a prognostic predictor for serous ovarian cancer patients and could potentially be targeted for immunotherapy. Additionally, ALOX5AP has been linked to immunosuppressive receptors in the tumor microenvironment, highlighting its significance in the immune-related tumor microenvironment of ovarian cancer.